Patents Assigned to Boston Scientific Neuromodulation Corporation
  • Patent number: 11724114
    Abstract: An implantable pulse generator (IPG) is disclosed having an improved ability to steer anodic and cathodic currents between the IPG's electrodes. Each electrode node has at least one PDAC/NDAC pair to source/sink or sink/source a stimulation current to an associated electrode node. Each PDAC and NDAC receives a current with a magnitude indicative of a total anodic and cathodic current, and data indicative of a percentage of that total that each PDAC and NDAC will produce in the patient's tissue at any given time, which activates a number of branches in each PDAC or NDAC. Each PDAC and NDAC may also receive one or more resolution control signals specifying an increment by which the stimulation current may be adjusted at each electrode. The current received by each PDAC and NDAC is generated by a master DAC, and is preferably distributed to the PDACs and NDACs by distribution circuitry.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: August 15, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Pujitha Weerakoon, David M. Wagenbach, Philip L. Weiss, Goran N. Marnfeldt, Kiran K. Gururaj
  • Patent number: 11707622
    Abstract: Methods and systems for facilitating the determining and setting of stimulation parameters for programming an electrical stimulation system are disclosed. The disclosed systems and methods use algorithms to identify patient-specific metrics to use as feedback variables for optimizing stimulation parameters for a patient. The patient-specific metric(s) are determined by ranking a plurality of clinical indicators for the patient with and without the presence of a medical intervention to determine which clinical indicators respond most strongly to the medical intervention. The clinical indicators that respond most strongly can be used as the patient-specific metric for optimizing stimulation, or a composite patient-specific metric may be derived as a mathematical combination of a plurality of clinical indicators that respond well to the intervention.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: July 25, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: León M. Juárez Paz
  • Patent number: 11697021
    Abstract: An implantable pulse generator (IPG) is disclosed having an improved ability to steer anodic and cathodic currents between the IPG's electrodes. Each electrode node has at least one PDAC/NDAC pair to source/sink or sink/source a stimulation current to an associated electrode node. Each PDAC and NDAC receives a current with a magnitude indicative of a total anodic and cathodic current, and data indicative of a percentage of that total that each PDAC and NDAC will produce in the patient's tissue at any given time, which activates a number of branches in each PDAC or NDAC. Each PDAC and NDAC may also receive one or more resolution control signals specifying an increment by which the stimulation current may be adjusted at each electrode. The current received by each PDAC and NDAC is generated by a master DAC, and is preferably distributed to the PDACs and NDACs by distribution circuitry.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: July 11, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Pujitha Weerakoon, David M. Wagenbach, Philip L. Weiss, Goran N. Marnfeldt
  • Patent number: 11697022
    Abstract: A group select matrix is added to an implantable stimulator device to allow current sources to be dedicated to particular groups of electrodes at a given time. The group select matrix can time multiplex the current sources to the different groups of electrodes to allow therapy pulses to be delivered at the various groups of electrodes in an interleaved fashion. Each of the groups of electrodes may be confined to a particular electrode array implantable at a particular non-overlapping location in a patient's body. A switch matrix can be used in conjunction with the group select matrix to provide further flexibility to couple the current sources to any of the electrodes.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: July 11, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Dongchul Lee
  • Patent number: 11691012
    Abstract: Methods and systems for electrical stimulation can include obtaining a biosignal of the patient; altering at least one stimulation parameter of an electrical stimulation system in response to the biosignal; and delivering an electrical stimulation current to one or more selected electrodes of the electrical stimulation system using the at least one stimulation parameter. In some embodiments, a power spectrum is determined from the biosignal. In some embodiments, the biosignal is at least two different biosignals measured at the same or different locations on the patient and a coherence, correlation, or association between the two biosignal is determined.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: July 4, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Hemant Bokil
  • Patent number: 11691014
    Abstract: An Example of a system for providing a patient with pain management may include a sleep monitoring circuit, a pain relief device, and a control circuit. The sleep monitoring circuit may be configured to sense one or more sleep signals from the patient and to determine a sleep state of the patient using the one or more sleep signals. The one or more sleep signals may include one or more physiological signals corresponding to the sleep state of the patient. The pain relief device may be configured to deliver one or more pain relief therapies. The control circuit may be configured to control the delivery of the one or more pain relief therapies using therapy parameters and to adjust the therapy parameters based on the determined sleep state.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: July 4, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kyle Harish Srivastava, Bryan Allen Clark, Elizabeth Mary Annoni, Jianwen Gu
  • Patent number: 11684779
    Abstract: An example of a system may include an electrode arrangement and a neuromodulation device configured to use electrodes in the electrode arrangement to generate a neuromodulation field. The neuromodulation device may include a neuromodulation generator, a neuromodulation control circuit and a storage. The storage may include a stochastically-modulated neuromodulation parameter set and the stochastically-modulated neuromodulation parameter set may include at least one stochastically-modulated parameter. The controller may be configured to control the neuromodulation generator using the stochastically-modulation parameter set to generate the neuromodulation field.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: June 27, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Changfang Zhu
  • Patent number: 11666761
    Abstract: An example of a system may include a processor and a memory device comprising instructions, which when executed by the processor, cause the processor to: access a patient metric of a subject; use the patient metric as an input to a machine learning algorithm, the machine learning algorithm to search a plurality of neuromodulation parameter sets and to identify a candidate neuromodulation parameter set of the plurality of neuromodulation parameter sets, the candidate neuromodulation parameter set designed to produce a non-regular waveform that varies over a time domain and a space domain; and program a neuromodulator using the candidate neuromodulation parameter set to stimulate the subject.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: June 6, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Natalie A. Brill, Jianwen Gu, Juan Gabriel Hincapie Ordonez, Changfang Zhu, Hemant Bokil, Stephen Carcieri
  • Patent number: 11654285
    Abstract: An example of a neurostimulation system may include a programming control circuit and a stimulation control circuit. The programming control circuit may be configured to program a stimulation device for delivering the neurostimulation according to a stimulation program specifying a present stimulation field set including stimulation field(s) each defined by a set of active electrodes selected from a plurality of electrodes. The stimulation control circuit may be configured to determine the stimulation program and may include field programming circuitry that may be configured to set the present stimulation field set to an initial stimulation field set specifying stimulation fields allowing for the delivery of the neurostimulation to produce an intended effect and to identify an optimal stimulation field set that satisfies one or more optimization criteria by removing stimulation field(s) from the initial stimulation field set.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: May 23, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Rafael Carbunaru
  • Patent number: 11648399
    Abstract: An example of an apparatus for percutaneously delivering neurostimulation energy to a patient and sensing from the patient using a test device placed externally to the patient is provided. The apparatus may include a stimulation lead, a sensing reference electrode, a sensing wire, and a connection system. The stimulation lead may be configured to be percutaneously introduced into the patient to place the one or more electrodes in the patient. The sensing reference electrode may be configured to be placed in the patient. The sensing wire may be connected to the sensing reference electrode and configured to be percutaneously introduced into the patient to place the sensing reference electrode in the patient. The connection system may be configured to mate the lead connector and the wire connector and to provide electrical connections between the lead connector and the test device and between the wire connector and the test device.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: May 16, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Joseph M. Bocek, Michael X. Govea, Rosana Esteller
  • Patent number: 11648403
    Abstract: An electrical stimulation system for use with a plurality of electrodes implanted within a tissue region comprises a neurostimulator configured for delivering electrical stimulation energy to the plurality of electrodes in accordance with a set of stimulation parameters, thereby injecting a charge into the tissue region, a control device configured for receiving user input to modify the set of stimulation parameters, and controller/processor circuitry configured for, in response to the user input computing a charge injection metric value as a function of a physical electrode parameter and an electrical source parameter for a first set of the electrodes, wherein the electrode set comprises at least two electrodes, comparing the computed charge injection metric value to a safety threshold value, and performing a corrective action based on the comparison.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: May 16, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Gustav Karl Steinke, Michael A. Moffitt
  • Patent number: 11638825
    Abstract: Systems and techniques are disclosed to establish programming of an implantable electrical neurostimulation device for treating chronic pain of a human subject, through the use of a dynamic model adapted to determine pain treatment parameters for a human patient and identify a new device operational program to implement the pain treatment parameters to address the chronic pain condition.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: May 2, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Qinghuang Lin, Jeffrey Rogers, Giovanni Russo, Andrea Simonetto, Tigran Tchrakian
  • Patent number: 11633226
    Abstract: Described herein are cannulas that comprise a cannula tube and a cannula tip. The cannula tube comprises a proximal end, a distal end, a cannula tube lumen, a sidewall, and a sidewall opening extending through the sidewall, the sidewall opening a proximal end and distal end. The cannula tip is secured to the distal end of the cannula tube and comprises a proximal tip portion that is inserted into the cannula tube lumen and a distal tip portion that extends beyond the distal end of the cannula tube. The cannula tip is configured to allow fluid to flow therethrough and is configured to eject a distal tip of an elongated device through the sidewall opening of the cannula tube as the elongated device is inserted through the cannula tube from the proximal end of the cannula tube.
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: April 25, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Himanshu Ranpura, Eric K. Nagaoka, Patrick M. Marek
  • Patent number: 11633608
    Abstract: A system and method for selecting leadwire stimulation parameters includes a processor iteratively performing, for each of a plurality of values for a particular stimulation parameter, each value corresponding to a respective current field: (a) shifting the current field longitudinally and/or rotationally to a respective plurality of locations about the leadwire; and (b) for each of the respective plurality of locations, obtaining clinical effect information regarding a respective stimulation of the patient tissue produced by the respective current field at the respective location; and displaying a graph plotting the clinical effect information against values for the particular stimulation parameter and locations about the leadwire, and/or based on the obtained clinical effect information, identifying an optimal combination of a selected value for the particular stimulation parameter and selected location about the leadwire at which to perform a stimulation using the selected value.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: April 25, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Stephen Carcieri, Dean Chen, Michael A. Moffitt
  • Patent number: 11633138
    Abstract: Sense amplifier circuits particularly useful in sensing neural responses in an Implantable Pulse Generator (IPG) are disclosed. The IPG includes a plurality of electrodes, with one selected as a sensing electrode and another selected as a reference to differentially sense the neural response in a manner that subtracts a common mode voltage (e.g., stimulation artifact) from the measurement. The circuits include a differential amplifier which receives the selected electrodes at its inputs, and comparator circuitries to assess each differential amplifier input to determine whether it is of a magnitude that is consistent with the differential amplifier's input requirements. Based on these determinations, an enable signal is generated which informs whether the output of the differential amplifier validly provides the neural response at any point in time.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: April 25, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Pujitha Weerakoon, Goran N. Marnfeldt
  • Patent number: 11628295
    Abstract: One embodiment is a lead introducer including an outer needle, an inner needle, a splittable member, and an annular seal member. The outer needle, inner needle, and splittable member each include a body and hub. The splittable member fits over the outer needle body and the inner needle body and can be separated longitudinally. The splittable member hub receives at least portions of both the inner needle hub and the outer needle hub within the splittable member hub. The annular seal member is formed by either a) the inner needle hub or b) a combination of the inner needle hub and outer needle hub. The annular seal member forms a fluid-resisting seal with the interior surface of the splittable member hub when the portions of the inner needle hub and outer needle hub are received within the splittable member hub.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: April 18, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: John M. Barker
  • Patent number: 11623097
    Abstract: An Implantable Pulse Generator (IPG) is disclosed that is capable of sensing a degree to which recruited neurons in a patient's tissue are firing synchronously, and of modifying a stimulation program to promote desynchronicity and to reduce paresthesia. An evoked compound action potential (ECAP) of the recruited neurons is sensed as a measure of synchronicity by at least one non-active electrode. An ECAP algorithm operable in the IPG assesses the shape of the ECAP and determines one or more ECAP shape parameters that indicate whether the recruited neurons are firing synchronously or desynchronously. If the shape parameters indicate significant synchronicity, the ECAP algorithm can adjust the stimulation program to promote desynchronous firing.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: April 11, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Bradley L. Hershey, Changfang Zhu
  • Patent number: 11623095
    Abstract: A system can utilize interleaving periods or waveforms to stimulate patient tissue and sense signals using the stimulation electrodes. For example, the system can utilize alternating therapeutic periods and sensing periods. As another example, the system can alternate between biphasic waveforms having opposite temporal orders of positive and negative phases. As another example, waveforms that differ in a parameter, such as amplitude or pulse width, can be interleaved to provide different information in the respective sensed signals.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: April 11, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Rosana Esteller, Goran N. Marnfeldt, Michael A. Moffitt
  • Patent number: 11612751
    Abstract: Methods and systems for programming stimulation parameters for an implantable medical device for neuromodulation, such as spinal cord stimulation (SCS) are disclosed. The stimulation parameters define user-configured waveforms having at least a first phase having a first polarity and a second phase having a second polarity, wherein the first and second phases are separated by an interphase interval (IPI). By delivering user-configured waveforms with different IPIs, stimulation geometry, and other waveform settings, therapeutic asynchronous activation of dorsal column fibers can be obtained.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: March 28, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Rosana Esteller
  • Patent number: 11612755
    Abstract: A connector and lead (or other elongated body) can produce a tactile sensation that indicates alignment between connector contacts of the connector and the terminals on the lead (or other elongated body). For example, a terminal or retention sleeve of the lead (or other elongated body) may include an indented circumferential groove that interacts with a connector contact or retention contact of the connector to produce the tactile sensation. As another example, one or more terminals or spacers may have a larger diameter than adjacent spacers or terminals to interact with a connector contact to produce the tactile sensation.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: March 28, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Ranjan Krishna Mukhari Nageri, Peter J. Yoo, Darragh McDermott